ETF Portfolio Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.11M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$776K |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$718K |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$494K |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$293K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$36.9K |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 0.39% |
| 2 | Healthcare | 0.37% |
| 3 | Communication Services | 0.28% |
| 4 | Industrials | 0.25% |
| 5 | Consumer Discretionary | 0.12% |
Similar funds
ETF Portfolio Partners's Q4 2019 Portfolio in Review
As of Q4 2019, ETF Portfolio Partners held 34 positions worth $189M, up 8.6% from $174M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
ETF Portfolio Partners deployed $5.93M of net new capital in Q4 2019, opening 2 new positions and adding to 24 existing holdings. Its largest new stake was Sarepta Therapeutics: 2,635 shares worth $340K.
By sector, the portfolio is most concentrated in Technology at 0.39% of assets, up from 0.32% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was iShares Core MSCI Total International Stock ETF, an estimated $36.9K trimmed.
- ETF Portfolio Partners's largest Q4 2019 buy was Sarepta Therapeutics: 2,635 shares worth $340K.
- ETF Portfolio Partners added most to iShares Core US Aggregate Bond ETF in Q4 2019, an estimated $1.11M increase.
- ETF Portfolio Partners's biggest Q4 2019 reduction was iShares Core MSCI Total International Stock ETF, cutting an estimated $36.9K.
- ETF Portfolio Partners's ten largest holdings make up 82% of its $189M portfolio in Q4 2019.
- ETF Portfolio Partners opened 2 new positions and closed 0 in Q4 2019.
- ETF Portfolio Partners's portfolio value rose 8.6% quarter-over-quarter to $189M.
Based on ETF Portfolio Partners's 13F filing for Q4 2019, filed 13 Jan 2020.